Cargando…
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations
Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Cal...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494264/ https://www.ncbi.nlm.nih.gov/pubmed/26344627 http://dx.doi.org/10.3390/vaccines2020463 |